CSL Limited: A Global Vaccine Manufacturing Company

Running head: FINANCE
Finance
Name of the Student:
Name of the University:
Author’s Note:

1
FINANCE
Overview
CSL or Commonwealth Serum Laboratories Limited is a global vaccine
manufacturing company founded in 1916, known for their speciality in biotechnology sector.
In the current time period, they manufacture innovative biotherapies and vaccines for
influenza and other virus to save people from life endangering medical situations and the
other products includes antivenoms, blood plasma derivatives and cell culture reagents (CSL
2018). CSL’s main goal which drives their passion is to save millions of patients from serious
medical conditions so as to live full and healthy lives.
CSL’s main functions include research, innovation, production and marketing of
products that treats and prevents complex medical conditions. The products they manufacture
are used for various medical and genetic research and manufacturing functions. CSL’s
operations are mainly divided into two segments, which are CSL Behring and Seqirus. The
CSL Behring segment’s role is to provide plasma remedies for cure of blood disorders,
respiratory diseases, immunodeficiency, neurological disorders, hereditary disorders,
haemolytic diseases in newborns, infections in organ transplants and treating patients with
acute major bleeding. This segment also performs research work on plasma and non-plasma
remedies (CSL 2018). On the other hand, the Seqirus segment is associated with the
productions and distribution of non-plasma bio therapeutic medicines, vaccines mainly
related to influenza and Q fever, and antivenoms.
CSL’s main headquarters is in Parkville, Australia. CSL Behring segment has it’s
headquarter in King of Prussia, USA. Its manufacturing facilities are in Swiss city (Bern),
Marburg (Germany), and in Kankakee (USA). CSL Seqirus segment is headquartered in
Maidenhead, UK, and it has its manufacturing laboratories in Holly Springs (USA),
Liverpool (UK), and Parkville (Australia).